Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 27 clinical trials
featured
Have been diagnosed with moderate to severe Ulcerative Colitis?

Have been diagnosed with moderate to severe Ulcerative Colitis?

  • 72 views
  • 08 Nov, 2020
  • 1 location
featured
PSA-006

PSA-006

  • 192 views
  • 23 Nov, 2020
  • 1 location
Efficacy Safety and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.

This clinical study will test the effects of a drug called apremilast in oligoarticular psoriatic arthritis with less than 2 years of disease duration. In previous studies, apremilast has been

apremilast
  • 265 views
  • 02 Jan, 2021
  • 177 locations
CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

disease. CF101 effect will be in comparison to apremilast in this study population

phototherapy
apremilast
serum pregnancy test
  • 26 views
  • 08 Jan, 2021
  • 45 locations
Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)

This is a single-center, open-label clinical study to study the efficacy of apremilast in the treatment of mild to moderate central centrifugal cicatricial alopecia. The investigators

  • 427 views
  • 05 Oct, 2020
  • 1 location
Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis

This study will evaluate the anti-pruritic effect of apremilast in patients with known PN.

control disease
  • 645 views
  • 08 Nov, 2020
  • 1 location
Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis

With limited treatment options available for dermatomyositis, the investigators hypothesize that apremilast, a phosphodiesterase-4 (PDE-4) inhibitor, is a safe and efficacious add-on treatment

  • 2 views
  • 10 Dec, 2020
  • 1 location
Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis

Researchers want to find out if giving the drug Apremilast in combination with Clobetasol spray can help people clear their moderate to severe plaque psoriasis quicker than if Apremilast is used

apremilast
plaque psoriasis
option 2
clobetasol
hormonal contraception
  • 10 views
  • 08 Nov, 2020
  • 1 location
Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast

). These are needed to maintain quality control of the normal levels of the biomarkers being tested. All treated psoriasis subjects will receive apremilast through Week 16

vasectomy
apremilast
phototherapy
cervical cap
  • 11 views
  • 30 Jul, 2020
  • 1 location
Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia

This is open label single side study involvement 20 patient treated with Apremilast. Each enrolled patient may be evaluated at by a dermatologist using the Lichen Planopilaris Activity Index and

  • 156 views
  • 08 Nov, 2020
  • 1 location